U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that when IBM conducted a market study of Chester Carlson's invention in 1959, the company concluded that it would take only 5000 units of his new product to saturate the market? IBM therefore declined to be part of the new product introduction. Too bad for IBM. Carlson's invention was the xerography process, and his new product was the beginning of the Xerox Corporation. It is estimated that every day, worldwide, 3,000,000,000 copies are made!!

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Examiner: Schwadron, Ronald B.


Primary examiner statistics: 117 patents; average approval time: 1931 days
Assistant examiner statistics: 9 patents; average approval time: 799 days

Patents as Primary Examiner (view all)

Patent No. Patent Title:
7425339 CD8alpha mutants
7422739 Anti-CD20 antibodies
7402410 Humanized immunoglobulin reactive with α4β7 integrin
7381560 Expression and use of anti-CD20 antibodies
7368119 Compositions and methods for WT1 specific immunotherapy
7364737 Human neutralizing monoclonal antibodies to respiratory syncytial...
7329410 Compositions and method for WT1 specific immunotherapy
7326535 Immunoreactive peptides from Epstein-Barr virus
7323181 Compositions and methods for WT1 specific immunotherapy
7291333 Blockade of protein C activation reduces microvascular surgical b...
7252829 HLA binding peptides and their uses
7252827 Conserved motif of hepatitis C virus E2/NS1 region
7226601 Conjugate between a modified superantigen and a target-seeking co...
7220559 Development of human monoclonal antibodies and uses thereof
7166423 Direct selection of cells by secretion product
7157091 MAGE-A1 peptides presented by HLA class II molecules
7147851 Humanized immunoglobulin reactive with α4β7 integrin
7144581 Compositions and methods for WT1 specific immunotherapy
7135185 Conserved motif of hepatitis C virus E2/NS1 region
7115272 Compositions and methods for WT1 specific immunotherapy
7112333 T cell epitopes of ryegrass pollen allergen
7098303 Conserved motif of hepatitis C virus E2/NS1 region
7097965 Targeting antigens to the MHC class I processing pathway with an ...
7070972 Janus family kinases and identification of immune modulators
7067284 Methods for producing antibody libraries using universal or rando...
7063854 Composition and methods for WTI specific immunotherapy
7060283 Immunoreactive peptides from Epstein-Barr virus
7037496 Chimeric immunoglobulin for CD4 receptors
7025962 Mammalian cell surface antigens; related reagents
6960472 Monoclonal antibodies against N-Terminus proBNP
6955900 Methods for producing polypeptide binding sites, monoclonal antib...
6946260 Allergen/inflammatory testing and diagnosis
6787153 Human monoclonal antibody specifically binding to surface antigen...
6770278 Methods of making and using immunoglobulin (Ig) compositions
6716425 Method of preventing cancer recurrence
6696061 Immunomodulatory peptides
6692907 Conserved motif of hepatitis C virus E2/NS1 region
6685942 Human neutralizing monoclonal antibodies to respiratory syncytial...
6682734 Therapeutic application of chimeric and radiolabeled antibodies t...
6669946 METHOD FOR IDENTIFYING INDIVIDUALS SUFFERING FROM A CELLULAR ABNO...

Patents as Assistant Examiner

Patent No. Patent Title:
5491218 Artificial positive controls derived from bifunctional conjugates
5478926 Monoclonal antibody against human IgE
5474770 Biological support for cell cultures constituted by plasma protei...
5468729 Method for treatment of autoimmune hepatitis
5434076 Tumor-specific, cell surface-binding monoclonal antibodies
5424288 Method of treating solid tumor cancers utilizing macro aggregated...
5322788 Monoclonal anti-body to cell surface protein of the bacterium ...
5275935 Amebic glycoconjugate and monoclonal antibody
5268455 Process for making biologically active polypeptides based on ...
 
Sign InRegister
Username  
Password   
forgot password?